(Nasdaq: CPIX), a specialty pharmaceutical company focused on delivering high-quality products to improve patient care, announced today the FDA has approved a supplemental New Drug Application ...
Today’s approval underscores the FDA’s continued commitment to advancing patient access to safe, effective and high quality generic drug products.” Hikma’s Liraglutide Injection is ...
“Today’s approval underscores the FDA’s continued commitment to advancing patient access to safe, effective and high-quality generic drug products,” Murphy added. Doctors are warning ...